Bath ASU Competitors and Similar CompaniesClear all
Bath ASU's competitors and similar companies include Travere Therapeutics, JCR Pharmaceuticals, Melinta Therapeutics and GBT (Global Blood Therapeutics).
 Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. |  Melinta Therapeutics Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
|  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. | ||
Founding Date | Founding Date 2006 | Founding Date 2011 | Founding Date 1975 | Founding Date 2000 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Corsham, GB HQ | Locations San Diego, US HQ Dublin, IE | Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP | Locations Morristown, US HQ New Haven, US | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB |
Employees | Employees 903% decrease | Employees 46293% increase | Employees 934 | Employees 1712% increase | Employees 352106% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.4 b | Valuation ($) 533.9 m | Valuation ($) N/A | Valuation ($) 4.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) ¥33.1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $194.7m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods $10.3m (FY, 2025) | Cost of goods ¥8b (FY, 2025) | Cost of goods N/A | Cost of goods $3.3m (FY, 2021) |
Gross profit | Gross profit N/A | Gross profit $480.4m (FY, 2025) | Gross profit ¥25.1b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($25.5m) (FY, 2025) | Net income (¥4.7b) (FY, 2025) | Net income N/A | Net income ($303.1m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 25m | Total funding raised N/A | Total funding raised $ 519.2m | Total funding raised $ 88.7m |
For sources of this data, please see the company profile
View Company Profiles
Travere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View companyJCR Pharmaceuticals
HQ
Ashiya, JP
Employees
934
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
View companyMelinta Therapeutics
HQ
Morristown, US
Employees
171↑ 2% increase
Melinta Therapeutics is an antibiotics-focused company that develops and commercializes antibiotics to overcome drug-resistant infections.
View companyGBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View company